?url_ver=Z39.88-2004&rft_id=MTMT%3A32049273+10.3389%2Fpore.2021.1609785&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.aufirst=Katalin&rft.aulast=Bo%C3%A9r&rft.au=+Bo%C3%A9r+Katalin&rft.volume=27&rft.issn=1219-4956&rft.date=2021&rft.title=PATHOLOGY+AND+ONCOLOGY+RESEARCH&rft.atitle=Pathologic+Complete+Response+Rates+After+Neoadjuvant+Pertuzumab+and+Trastuzumab+with+Chemotherapy+in+Early+Stage+HER2-Positive+Breast+Cancer+-+Increasing+Rates+of+Breast+Conserving+Surgery%3A+A+Real-World+Experience&rft.genre=article